Scythian Biosciences (CSE:SCYB) announced a shift in its strategic focus to be on the US medical cannabis market exclusively.
As quoted in the press release:
“The United States represents the single biggest opportunity in the global medical cannabis marketplace, and Scythian is excited to shift its focus to becoming one of the leading operators in the space,” CEO Rob Reid stated.
This follows on from the recent announcement that it will take a controlling interest in 3 Boys Farms LLC, an established Florida medical cannabis company as well as a complementary Florida-based, multi-specialty primary care / health and wellness medical organization. With this combined acquisition and the key executives and personnel in both organizations who are experts in their field, Scythian is poised to become one of the leading medical cannabis companies but also one of the foremost health and wellness companies in the State.
“Florida has a population that is nearly as large as Canada and boasts the highest population over the age of 65 in North America, so to say that we are excited about executing upon our plan in Florida would be an understatement,” Rob Reid continued.